相本

  • Gwo Xi Stem Cell’s Novel Stroke Therapy GXNPC1 Pub
    23
    2025
    12
    Publications

    Gwo Xi Stem Cell’s Novel Stroke Therapy GXNPC1 Pub

    Gwo Xi Stem Cell’s novel stem cell therapy for stroke, GXNPC1®, has had its latest research findings published in the international academic journal The ACTO Times (Vol. 2, Issue 4, Autumn 2025) under the title “Gwo Xi’s stem cell product GXNPC1 shows safety and beneficial effect for stroke patients.”

  • Clinical-Grade Stem Cell as Starting Material (
    20
    2025
    11
    Brochures

    Clinical-Grade Stem Cell as Starting Material (

  • Stem Cell Therapy: Autologous vs. Allogeneic Appro
    03
    2025
    11
    Publications

    Stem Cell Therapy: Autologous vs. Allogeneic Appro

    In clinical practice, Stem Cell Therapy (also known as Regenerative Medicine) involves a treatment process where cells are professionally processed prior to administration. The stem cells must be harvested from the human body and undergo rigorous processing, such as purification, isolation, culture, and quality testing. This meticulous processing ensures the quality of the final cell-based product before it is administered into the patient's body to repair damaged tissues, modulate the immune system, and promote the regeneration of organs and tissues.

  • How Do EXOSOMES Work in Aesthetic Medicine: Unlock
    27
    2025
    10
    Publications

    How Do EXOSOMES Work in Aesthetic Medicine: Unlock

    In recent years, regenerative medicine has progressed alot. After unveiling stem cells’ regenerative potential, scientists began to explore the beneficial  effects of exosome in the field of  organ/tissue repair and anti-aging. Because stem cell therapies are costly and risky for the reasons like self-copy and tumorigenesis, exosomes secreted by stem cells, with high safety and biocompatibility profiles, have become a key bridge between regenerative medicine and various industries. Exosomes are constantly discussed and explored in the realm of aesthetic skincare.

  • What Are Exosomes? Decoding Stem Cell Exosome Prop
    21
    2025
    10
    Publications

    What Are Exosomes? Decoding Stem Cell Exosome Prop

    Exosomes are nanoscale extracellular vesicles (EVs) secreted by cells, ranging in size from 30 to 150 nanometers (nm). They are commonly found in bodily fluids such as blood, urine, saliva, and others.

  • Exosome Hair Growth Therapy: Say Goodbye to Male P
    17
    2025
    10
    Publications

    Exosome Hair Growth Therapy: Say Goodbye to Male P

    Exosome-based hair regrowth takes a different approach. It is minimally invasive and combines tissue repair with follicle activation.

  • Cosmetic Ingredient: hMSC-Exos
    05
    2025
    08
    Brochures

    Cosmetic Ingredient: hMSC-Exos

  • Company Profile
    05
    2025
    08
    Brochures

    Company Profile

  • MSC-Exo CDMO Service
    05
    2025
    08
    Brochures

    MSC-Exo CDMO Service

  • What Is Licensing Transaction in Pharmaceutical In
    21
    2025
    07
    Publications

    What Is Licensing Transaction in Pharmaceutical In

    Licensing Transactions are a common collaboration model in the biotech and pharmaceutical industry.

  • GXNPC1® (Chronic Stroke)
    11
    2025
    07
    Academy

    GXNPC1® (Chronic Stroke)

    GXNPC1® has demonstrated significant neurological improvement in patients with chronic stroke.

  • GXCPC1® (Knee Osteoarthritis)
    10
    2025
    07
    Academy

    GXCPC1® (Knee Osteoarthritis)

    This study showed that the intra-articular administration of GXCPC1®, an allogeneic adipose-derived stem cell, was safe and well-tolerated in subjects with therapeutic alternatives to treat knee osteoarthritis (knee OA) during 1 year follow-up period.

  • GXHPC1® (Liver Cirrhosis)
    09
    2025
    07
    Academy

    GXHPC1® (Liver Cirrhosis)

    GXHPC1® demonstrated favorable safety and efficacy in its Phase I human clinical trial. No safety concerns were observed during follow-up period, and patients with liver cirrhosis showed a tendency of improvements for liver function, METAVIR score, Child–Pugh score, MELD score, and quality of life.

  • GXIPC1®  (Type I Diabetes)
    08
    2025
    07
    Academy

    GXIPC1® (Type I Diabetes)

    The results demonstrated that transplantation of hIPCs significantly alleviates hyperglycemia in streptozotocin-induced diabetic rats, offering a promising approach for safe and cost-effective diabetes treatment.

  • GX Factor® (Growth Factor)
    07
    2025
    07
    Academy

    GX Factor® (Growth Factor)

    PRFr (GX Factor®) releases abundant of growth factors such as PDGF-AB, IGF-1, and TGF-β1 within 300 minutes, suggesting that GX Factor® can effectively enhance growth factor release and promote wound healing.

  • The Application of Cardiovascular Disease
    07
    2025
    07
    Academy

    The Application of Cardiovascular Disease

    In this study, it showed that BP-primed human adipose-derived stem cells (BP-pretreated hADSCs) significantly reduced arrhythmias following myocardial infarction and enhanced the cells’ cardioprotective effects via the PI3K/Akt/GSK-3β pathway.

  • What Makes Stem Cell Medicines Different from Trad
    25
    2025
    04
    Publications

    What Makes Stem Cell Medicines Different from Trad

    With advances in medical science, the ways we treat disease are continuously evolving.

  • What Is an INCI Name? Can Stem Cell-Derived Exosom
    21
    2025
    03
    Publications

    What Is an INCI Name? Can Stem Cell-Derived Exosom

    INCI name serves as a trusted resource for the cosmetics industry and researchers, helping ensure consumer safety and transparency.